Arax Advisory Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41K | Sell |
51
-8
| -14% | -$221 | ﹤0.01% | 2668 |
|
|
2025
Q1 | $1.67K | Sell |
59
-262
| -82% | -$7.43K | ﹤0.01% | 2121 |
|
|
2024
Q4 | $13.3K | Buy |
321
+219
| +215% | +$9.11K | ﹤0.01% | 1377 |
|
|
2024
Q3 | $6.82K | Hold |
102
| – | – | ﹤0.01% | 1574 |
|
|
2024
Q2 | $12.1K | Sell |
102
-198
| -66% | -$23.5K | ﹤0.01% | 1174 |
|
|
2024
Q1 | $32K | Buy |
+300
| New | +$32K | ﹤0.01% | 579 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$117K | – | 1048 |
|
|
2021
Q2 | $117K | Buy |
+500
| New | +$117K | 0.02% | 306 |
|